We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICFI icon
1226
ICF International
ICFI
$1.6B
$970K 0.01%
9,796
+120
+1% +$13.1K
SYBT icon
1227
Stock Yards Bancorp
SYBT
$2.64B
$969K 0.01%
14,911
ROIC
1228
DELISTED
Retail Opportunity Investments Corp.
ROIC
$966K 0.01%
64,279
PACB icon
1229
Pacific Biosciences
PACB
$357M
$964K 0.01%
117,859
MDC
1230
DELISTED
M.D.C. Holdings, Inc.
MDC
$963K 0.01%
30,469
KNBE
1231
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$962K 0.01%
38,808
OII icon
1232
Oceaneering
OII
$5.11B
$960K 0.01%
54,915
CERE
1233
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$959K 0.01%
30,419
+1,578
+5% +$44.5K
ODP
1234
DELISTED
ODP
ODP
$957K 0.01%
21,022
-3,189
-13% -$136K
CORT icon
1235
Corcept Therapeutics
CORT
$11.9B
$957K 0.01%
47,099
VIR icon
1236
Vir Biotechnology
VIR
$1.52B
$956K 0.01%
37,757
CTRE icon
1237
CareTrust REIT
CTRE
$9.18B
$955K 0.01%
51,406
DOCN icon
1238
DigitalOcean
DOCN
$15.6B
$955K 0.01%
37,477
SMTC icon
1239
Semtech
SMTC
$12.4B
$954K 0.01%
33,241
-40,828
-55% -$1.16M
HLIO icon
1240
Helios Technologies
HLIO
$2.67B
$953K 0.01%
17,500
CPE
1241
DELISTED
Callon Petroleum Company
CPE
$951K 0.01%
25,637
-1,379
-5% -$56.6K
AMRC icon
1242
Ameresco
AMRC
$1.47B
$951K 0.01%
16,637
NVEE
1243
DELISTED
NV5 Global
NVEE
$951K 0.01%
28,736
LKFN icon
1244
Lakeland Financial Corp
LKFN
$1.56B
$950K 0.01%
13,025
NBTB icon
1245
NBT Bancorp
NBTB
$2.79B
$948K 0.01%
21,828
+369
+2% +$16.3K
APAM icon
1246
Artisan Partners
APAM
$3.03B
$946K 0.01%
31,846
-1,473
-4% -$45.3K
INSW icon
1247
International Seaways
INSW
$4.71B
$943K 0.01%
25,479
LNN icon
1248
Lindsay Corp
LNN
$1.17B
$942K 0.01%
5,785
-236
-4% -$38.9K
DOOR
1249
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$942K 0.01%
11,682
DBRG icon
1250
DigitalBridge
DBRG
$2.94B
$942K 0.01%
86,073

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.